awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36953028-B78FBB24-F6FB-44F5-8640-2D94FE53F389
Q36953028-B78FBB24-F6FB-44F5-8640-2D94FE53F389
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36953028-B78FBB24-F6FB-44F5-8640-2D94FE53F389
Targeting the androgen receptor pathway in prostate cancer.
P2860
Q36953028-B78FBB24-F6FB-44F5-8640-2D94FE53F389
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36953028-B78FBB24-F6FB-44F5-8640-2D94FE53F389
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b49af10acbcc789ee6527e10d819a8223e6e227b
P2860
A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer.